Bruker Corporation last reported quarterly results on Nov 4, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $874.0 million (+1.6% year over year) and diluted EPS of -$0.81. It usually reports 12–36 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 11, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Monday. Based on last year's release for the same quarter on Jan 12, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 12–36 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 4, 2026
35 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
874
+1.6%
|
-112
-87.6%
|
-0.81
-97.6%
|
|
Aug 4, 2026
35 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
838
+5.2%
|
-52
-784.2%
|
-0.41
-920.0%
|
|
May 6, 2026
36 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
823
+2.7%
|
14
-17.2%
|
0.02
-81.8%
|
|
Jan 12, 2026
12 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
977
-0.2%
|
26
+89.8%
|
0.10
+8.6%
|
|
Nov 3, 2025
34 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
860
-0.5%
|
-60
-245.7%
|
-0.41
-251.9%
|
|
Jul 21, 2025
21 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
797
-0.4%
|
8
+0.0%
|
0.05
+0.0%
|
|
Apr 11, 2025
11 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
801
+11.0%
|
17
-65.8%
|
0.11
-68.6%
|
|
Jan 13, 2025
13 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
980
+14.6%
|
14
-93.3%
|
0.09
-74.4%
|
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- BRKR (Nasdaq), BRKRP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Billerica, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1109354
- Former names
- BRUKER BIOSCIENCES CORP (until Feb 27, 2008); BRUKER DALTONICS INC (until Jul 2, 2003)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- 10x Genomics, Inc. TXG
Source: SEC EDGAR filings. This is company-reported data, not investment advice.